Market Cap (In KRW)
2282.86 Billion
Revenue (In KRW)
3.34 Billion
Net Income (In KRW)
-15.92 Billion
Avg. Volume
1.36 Million
- Currency
- KRW
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 21100.0-132000.0
- PE
- -
- EPS
- -
- Beta Value
- 0.740753
- ISIN
- KR7087010005
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Ho-Il Choi
- Employee Count
- -
- Website
- http://www.peptron.co.kr
- Ipo Date
- 2015-07-22
- Details
- Peptron, Inc. engages in the development of peptide-based medicines to treat chronic diseases. The company's technologies include long acting; and SmartDepot, an ultrasonic spray drying technology for the preparation of sustained release injectable microsphere formulation of drug. Its research and development products include Luphere Depot for prostate cancer, endometriosis, uterine fibroids, and puberty; SR-Octreotide (PT201) for the treatment of acromegaly; SR-Exenatide (PT302) to treat type 2 diabetes; and SR-Exenatide (PT320) for Parkinson's and Alzheimer's disease. Peptron, Inc. was founded in 1997 and is headquartered in Daejeon, South Korea.
More Stocks
-
006340Daewon Cable. Co., Ltd.
006340
-
GRZ
-
601099
-
214330Kumho HT, Inc
214330
-
BLOBloober Team SA
BLO
-
281820KCTech Co., Ltd.
281820
-
BIHSPONGBihar Sponge Iron Limited
BIHSPONG
-
NCODNorcod AS
NCOD